Market Place
Sourcing Support
Genentech`s Giredestrant Shows Superior iDFS in Breast Cancer
18 Nov 2025 //
BUSINESSWIRE
Roche`s Appeal Denied By Supreme Court In Risdiplam Generic Drug
17 Oct 2025 //
BUSINESS STD
Roche Challenges Natco`s Generic Risdiplam Launch In India
14 Oct 2025 //
ECONOMICTIMES
Natco Wins Patent Battle To Launch Generic `Risdiplam`
11 Oct 2025 //
ECONOMICTIMES
Roche to Investigate Whether Drug can Delay or Prevent Alzheimer
29 Jul 2025 //
REUTERS
NATCO Pharma updates on legal proceedings for Risdiplam launch
08 Apr 2025 //
INDPHARMAPOST
Roche files patent suit to fend off potential Evrysdi generics
20 Nov 2024 //
FIERCE PHARMA
Roche partners with Ascidian Therapeutics to develop gene therapies
19 Jun 2024 //
REUTERS
Roche is `evaluating options` for IPF drug Esbriet as generics gain traction
27 Feb 2024 //
ENDPTS
Roche sues Novartis unit over generic lung disease drug
02 Aug 2023 //
REUTERS
Several generics makers report shortages of Roche`s Tamiflu
21 Dec 2022 //
FIERCEPHARMA
Romania Fines Roche $14M for Undermining Biosimilar, Generic Competition
28 Jan 2020 //
RAPS
Where is that Sandoz U.S. generics deal with Aurobindo?
24 Oct 2019 //
FIERCE PHARMA
Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc.
20 Aug 2019 //
PATENT DOCS
Pfizer To Launch Several Drugs Despite Generic Headwinds
05 Jun 2019 //
BIOSIMILAR DEVELOPMENT
Gilead`s $3B-per-year Truvada to face generics a year early
09 May 2019 //
FIERCE PHARMA
Celltrion gets FDA approval for antibiotic generic
09 May 2019 //
IN-PHARMATECHNOLOGIST
As generic competition stutter sales of top oncology drugs
19 Feb 2019 //
ENDPTS
AbbVie, Roche, Pfizer cited for `exploitative` patent strategy
07 Aug 2018 //
FIERCE PHARMA
I-MAK Report Calls AbbVie "The Worst Patent Offender" in Pharma
07 Aug 2018 //
CENTER FOR BIOSIMILARS
Patent abuse driving high drug prices, non-profit claims
02 Aug 2018 //
LIFESCIENCE PREVIEW
Herceptin® (Trastuzumab) :Genentech, Inc. et al v. Celltrion, Inc. et al
16 Jul 2018 //
PATENT LITIGATION
Rituxan® (Rituximab): Genentech, Inc. et al v. Celltrion, Inc. et al
16 Jul 2018 //
PATENT LITIGATION
China answers outcry over cancer drug prices with speedy cuts
10 Jul 2018 //
FIERCE PHARMA
FDA Calls Out Pharma Cos for Blocking Requests from Generic Manufacturers
18 May 2018 //
BIOSPACE
Who’s delaying generic competition? FDA publishes list of drugmakers
17 May 2018 //
ENDPTS
The top 15 patent expirations of 2018
03 Apr 2018 //
FIERCE PHARMA
Rituxan®(Rituximab): Genentech v. Celltrion
12 Jan 2018 //
PATENT LITIGATION
Pharmaceutical Earnings: It’s All About The Fundamentals
14 Jul 2017 //
BARRONS
Setback for Roche: Mylan, Biocon can now sell generics of its cancer drug
04 Mar 2017 //
BUSINESS-STANDARD
Generic Copy of Roche Flu Pill Tamiflu hits US Market
13 Dec 2016 //
REUTERS
Novartis Looks at Up to $5 Billion Deals in Cancer, Generics
25 Oct 2016 //
BLOOMBERG
Despite Generic Erosion of Current Market, Asthma Market Will Remain Steady
22 Sep 2015 //
PR NEWS WIRE
DME data helps Eylea soar in Q2--and poach market share from its Roche rivals
04 Aug 2015 //
FIERCEPHARMA
AstraZeneca Strikes Deal to Develop Version of Roche’s Avastin
25 Jul 2015 //
SWISS INFO
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
22 Jul 2015 //
FIERCE PHARMA MARKETING
